As key members of the probiotic research community, the Lab4 team regularly contribute to articles in magazines, journals and other publications both online and offline.
Michael DR. Bacteria help for healthier hearts. Advances Wales 2016; 79: 14
A collaborative study between Cardiff University and Cultech Ltd has found that friendly bacteria can play a role in helping to prevent high blood cholesterol levels, and support current treatment programmes for heart disease. This study used cell-based experimental models to identify a strain of friendly bacteria that may be able to help lower blood cholesterol levels. The presence of Lactobacillus plantarum CUL66 could alter the behaviour of the major cholesterol absorbing cells of the intestines and reduce their ability to transport cholesterol.
Pevac-Djukic M, Plummer S, Garaiova I. Probiotics and the Gastrointestinal Health. Naturopathic Doctor News and Review 2010 (January), 6 (1):8-10
The scope of probiotics seems endless! It seems that more and more applications for the involvement of probiotic supplements are being identified, almost on a daily basis. There are inconsistencies in the results that have been obtained but much of that relates to the testing of a diversity of products with different compositions and potencies. It is apparent that there are benefits from probiotics across a broad spectrum of conditions, many of which are linked with antibiotic therapy. As our knowledge of the value of the gastrointestinal microbiota is growing, so is the awareness of the potential for probiotics and as the mechanistic details of the mode of action of probiotics becomes clearer, further developments will occur. Overall, the message for probiotics and the gastrointestinal tract is “watch this space”.
Plummer S, Garaiova I. Can probiotics impact the development of allergy in infants? Integrated Healthcare Practitioners Magazine 2008 (June/July)
There is an absolute requirement for postnatal development of a balanced immune system and it would appear that one of the primary signals for such maturation involves stimulation from the commensal microbiota, particularly the gastrointestinal microbiota. Thus, there is a need/justification for supplementation with probiotics to ensure the establishment of a stable, balanced neonatal intestinal microbiota. In the longer term greater insight into the association between the gut microbiota and atopic diseases requires further large scale prospective birth cohort studies such as the PROBAT study (Morgan 2005).
Madden J. Dietary Management of Irritable Bowel Syndrome. www.readbusiness.co.uk. Nutrition, 11th April 2003: 45-49.
IBS is a common disorder and is potentially incapacitating. However, symptoms can often be managed by the patient themselves making minor modifications to their own diet and/or lifestyle. In more severe cases, where the symptoms are debilitating, the guidance of a GP or practice nurse will be necessary. The practice nurse may be the first medical contact for new IBS patients and so should be aware of the range of symptoms. There is evidence to suggest that an altered intestinal microflora may play a part in the pathogenesis of IBS or in its manifestation. Dietary supplements, such as probiotics, may be helpful in alleviating symptoms.